These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4211032)

  • 1. Carbon-13 nuclear magnetic resonance studies of structure and function in thyrotropin-releasing factor. Determination of the tautomeric form of histidine and relationship to biology activity.
    Deslauriers R; McGregor WH; Sarantakis D; Smith IC
    Biochemistry; 1974 Aug; 13(17):3443-8. PubMed ID: 4211032
    [No Abstract]   [Full Text] [Related]  

  • 2. 1H nuclear magnetic resonance studies of thyrotropin releasing factor (TRF).
    Feeney J; Bedford GR; Wessels PL
    FEBS Lett; 1974 Jun; 42(3):347-51. PubMed ID: 4369451
    [No Abstract]   [Full Text] [Related]  

  • 3. Orientation restrictions of the peptide hormone, thyrotropin-releasing factor, due to intramolecular hydrogen bonding.
    Grant G; Ling N; Rivier J; Vale W
    Biochemistry; 1972 Aug; 11(16):3070-3. PubMed ID: 4625316
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbon-13 nuclear magnetic resonance studies on thyrotropin-releasing factor and related peptides.
    Deslauriers R; Garrigou-Lagrange C; Bellocq AM; Smith UC
    FEBS Lett; 1973 Apr; 31(1):59-66. PubMed ID: 4196901
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and conformational studies by 1H- and 13C-NMR spectroscopy of a novel, sterically constrained analogue of thyrotropin-releasing hormone.
    Mapelli C; Van Halbeek H; Stammer CH
    Biopolymers; 1990 Feb; 29(2):407-22. PubMed ID: 2158826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the tautomeric form of the imidazole ring of L-histidine in basic solution by carbon-13 magnetic resonance spectroscopy.
    Reynolds WF; Peat IR; Freedman MH; Lyerla JR
    J Am Chem Soc; 1973 Jan; 95(2):328-31. PubMed ID: 4687673
    [No Abstract]   [Full Text] [Related]  

  • 7. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    Biochem Biophys Res Commun; 1973 Jul; 53(1):244-50. PubMed ID: 4354931
    [No Abstract]   [Full Text] [Related]  

  • 8. Intramolecular assistance of cis/trans isomerization of the histidine-proline moiety.
    Reimer U; el Mokdad N; Schutkowski M; Fischer G
    Biochemistry; 1997 Nov; 36(45):13802-8. PubMed ID: 9374856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon-13 NMR studies of peptide hormones and their components.
    Smith IC; Deslauriers R; Saitô H; Walter R; Garrigou-Lagrange C; McGregor H; Sarantakis D
    Ann N Y Acad Sci; 1973 Dec; 222():597-627. PubMed ID: 4361873
    [No Abstract]   [Full Text] [Related]  

  • 10. Conformational mobility of the pyrrolidine ring of proline in peptides and peptide hormones as manifest in carbon 13 spin-lattice relaxation times.
    Deslauriers R; Smith IC; Walter R
    J Biol Chem; 1974 Nov; 249(21):7006-10. PubMed ID: 4371430
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of nitrogen-15-labeled amino acids and peptides by nuclear magnetic resonance spectroscopy.
    Sogn JA; Gibbons WA; Randall EW
    Biochemistry; 1973 May; 12(11):2100-5. PubMed ID: 4705988
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone: biosynthesis by rat hypothalamic fragments in vitro.
    Mitnick M; Reichlin S
    Science; 1971 Jun; 172(3989):1241-3. PubMed ID: 4995924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational analysis of thyrotropin releasing factor.
    Burgess AW; Momany FA; Scheraga HA
    Proc Natl Acad Sci U S A; 1973 May; 70(5):1456-60. PubMed ID: 4197091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionization behavior of the histidine residue in the catalytic triad of serine proteases. Mechanistic implications.
    Hunkapiller MW; Smallcombe SH; Witaker DR; Richards JH
    J Biol Chem; 1973 Dec; 248(23):8306-8. PubMed ID: 4201783
    [No Abstract]   [Full Text] [Related]  

  • 15. The distribution of radioactivity following the administration of labeled thyrotropin-releasing hormone (TRH) in rats and mice.
    Redding TW; Schally AV
    Endocrinology; 1971 Oct; 89(4):1075-81. PubMed ID: 4999144
    [No Abstract]   [Full Text] [Related]  

  • 16. 13C-nuclear magnetic resonance study of [85% 13C-enriched proline]thyrotropin releasing factor: 13C-13C vicinal coupling constants and conformation of the proline residue.
    Haar W; Fermandjian S; Vicar J; Blaha K; Fromageot P
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4948-52. PubMed ID: 813218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spin-lattice relaxation times of imidazole protons and their relevance to NMR studies of proteins.
    Wasylishen RE; Cohen JS
    Nature; 1974 Jun; 249(460):847-50. PubMed ID: 4209741
    [No Abstract]   [Full Text] [Related]  

  • 18. Nuclear magnetic resonance studies of thyrotropin-releasing hormone (TRH) and analogues incorporating D-histidine and 4-hydroxy-L-proline.
    Aksnes DW; Athanassopoulos C; Magafa V; Aaberg A; Francis GW; Papaioannou D
    Acta Chem Scand (Cph); 1996 May; 50(5):411-6. PubMed ID: 8634183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon-13 nuclear magnetic resonance investigations of hormone structure and function.
    Smith IC; Deslauriers R
    Recent Prog Horm Res; 1976; 33():309-32. PubMed ID: 801193
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thyrotropin-releasing factor (TRF)].
    Studer R; Werner I
    Schweiz Med Wochenschr; 1970 Jun; 100(25):1086-7. PubMed ID: 5004059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.